2020
Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients
Gaston DC, Malinis M, Osborn R, Peaper DR, Landry M, Juthani-Mehta M, Azar MM. Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients. American Journal Of Transplantation 2020, 21: 1304-1311. PMID: 33043603, PMCID: PMC7675520, DOI: 10.1111/ajt.16357.Peer-Reviewed Original ResearchConceptsSolid organ transplant recipientsOrgan transplant recipientsClinical implicationsCycle threshold valuesSOT patientsTransplant recipientsSymptom onsetYale New Haven Health SystemUpper respiratory tract samplesSARS-CoV-2 viral RNASARS-CoV-2 viral dynamicsAdult SOT recipientsRetrospective chart reviewRespiratory tract samplesSARS-CoV-2 cycle threshold valuesInfection prevention measuresCOVID-19 severityViral RNAHigher clinical acuityPrimary diagnostic testRT-PCR assaysSOT recipientsChart reviewViral loadAdmission severity
2000
A Multisite Trial Comparing Two Cytomegalovirus (CMV) pp65 Antigenemia Test Kits, Biotest CMV Brite and Bartels/Argene CMV Antigenemia
St. George K, Boyd M, Lipson S, Ferguson D, Cartmell G, Falk L, Rinaldo C, Landry M. A Multisite Trial Comparing Two Cytomegalovirus (CMV) pp65 Antigenemia Test Kits, Biotest CMV Brite and Bartels/Argene CMV Antigenemia. Journal Of Clinical Microbiology 2000, 38: 1430-1433. PMID: 10747120, PMCID: PMC86458, DOI: 10.1128/jcm.38.4.1430-1433.2000.Peer-Reviewed Original ResearchConceptsPp65 antigenemiaTransplant recipientsHuman immunodeficiency virus-positive patientsImmunodeficiency virus-positive patientsBone marrow transplant recipientsCMV pp65 antigenemiaOrgan transplant recipientsVirus-positive patientsMarrow transplant recipientsPositive cell countsPeripheral blood leukocytesNegative predictive valueCMV antigenemiaBlood leukocytesAntigenemiaBlood specimensPredictive valueCell countMultisite trialCytomegalovirusStatistical differenceTotalTest kitRecipientsKit